Search

Your search keyword '"Ferrari, Giulia Maria"' showing total 18 results
Start Over Author "Ferrari, Giulia Maria"
18 results on '"Ferrari, Giulia Maria"'

2. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group

Author

Corti, Paola, primary, Ferrari, Giulia Maria, additional, Faraguna, Martha Caterina, additional, Capitoli, Giulia, additional, Longo, Filomena, additional, Corradini, Elena, additional, Casini, Tommaso, additional, Boscarol, Gianluca, additional, Pinto, Valeria Maria, additional, Ghilardi, Roberta, additional, Russo, Giovanna, additional, Colombatti, Raffaella, additional, Mariani, Raffaella, additional, and Piperno, Alberto, additional

Published
2023
Full Text
View/download PDF

3. Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group.

Author

Corti, Paola, Ferrari, Giulia Maria, Faraguna, Martha Caterina, Capitoli, Giulia, Longo, Filomena, Corradini, Elena, Casini, Tommaso, Boscarol, Gianluca, Pinto, Valeria Maria, Ghilardi, Roberta, Russo, Giovanna, Colombatti, Raffaella, Mariani, Raffaella, and Piperno, Alberto

Subjects
*HEMOCHROMATOSIS, *IRON chelates, *GAIN-of-function mutations, *MORPHOGENESIS, *GENETIC disorders
Abstract

Summary: Haemochromatosis (HC) encompasses a range of genetic disorders. HFE‐HC is by far the most common in adults, while non‐HFE types are rare due to mutations of HJV, HAMP, TFR2 and gain‐of‐function mutations of SLC40A1. HC is often unknown to paediatricians as it is usually asymptomatic in childhood. We report clinical and biochemical data from 24 paediatric cases of HC (10 cases of HFE‐, 5 TFR2‐, 9 HJV‐HC), with a median follow‐up of 9.6 years. Unlike in the adult population, non‐HFE‐HC constitutes 58% (14/24) of the population in our series. Transferrin saturation was significantly higher in TFR2‐ and HJV‐HC compared to HFE‐HC, and serum ferritin and LIC were higher in HJV‐HC compared to TFR2‐ and HFE‐HC. Most HFE‐HC subjects had relatively low ferritin and LIC at the time of diagnosis, so therapy could be postponed for most of them after the age of 18. Our results confirm that HJV‐HC is a severe form already in childhood, emphasizing the importance of early diagnosis and treatment to avoid the development of organ damage and reduce morbidity and mortality. Although phlebotomies were tolerated by most patients, oral iron chelators could be a valid option in early‐onset HC. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity

Author

Guerra, Fabiola, primary, L’Imperio, Vincenzo, additional, Bonanomi, Sonia, additional, Spinelli, Marco, additional, Coliva, Tiziana Angela, additional, Dell’Acqua, Fabiola, additional, Ferrari, Giulia Maria, additional, Corti, Paola, additional, Balduzzi, Adriana, additional, Biondi, Andrea, additional, Pagni, Fabio, additional, and Saettini, Francesco, additional

Published
2022
Full Text
View/download PDF

6. Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity

Author

Guerra, F, L'Imperio, V, Bonanomi, S, Spinelli, M, Coliva, T, Dell'Acqua, F, Ferrari, G, Corti, P, Balduzzi, A, Biondi, A, Pagni, F, Saettini, F, Guerra, Fabiola, L'Imperio, Vincenzo, Bonanomi, Sonia, Spinelli, Marco, Coliva, Tiziana Angela, Dell'Acqua, Fabiola, Ferrari, Giulia Maria, Corti, Paola, Balduzzi, Adriana, Biondi, Andrea, Pagni, Fabio, Saettini, Francesco, Guerra, F, L'Imperio, V, Bonanomi, S, Spinelli, M, Coliva, T, Dell'Acqua, F, Ferrari, G, Corti, P, Balduzzi, A, Biondi, A, Pagni, F, Saettini, F, Guerra, Fabiola, L'Imperio, Vincenzo, Bonanomi, Sonia, Spinelli, Marco, Coliva, Tiziana Angela, Dell'Acqua, Fabiola, Ferrari, Giulia Maria, Corti, Paola, Balduzzi, Adriana, Biondi, Andrea, Pagni, Fabio, and Saettini, Francesco

Abstract

Myelofibrosis is a rare myeloproliferative disorder. The detailed descriptions of myelofibrosis in children and adolescents is limited to a few case series and case reports describing fewer than 100 patients, thus suggesting the extreme rarity of this condition prior to adulthood. Though pediatric patients rarely present the typical features and outcomes usually observed in older people, pediatric myelofibrosis is not considered an independent entity. Here we aim to describe patients with pediatric myelofibrosis, showing different clinical and pathological features when compared to the World Health Organization 2016 Primary Myelofibrosis classification. We retrospectively collected and analyzed 14 consecutive pediatric myelofibrosis diagnosed in our Pediatric hematology outpatient clinic over a six-year period. According to clinical data and bone marrow biopsy findings, patients were classified into three subgroups: adult-like myelofibrosis, pediatric immune myelofibrosis, idiopathic myelofibrosis. Pediatric Immune Myelofibrosis was the predominant subgroup in our cohort (7/14). Pediatric Immune Myelofibrosis is characterized by peculiar bone marrow features (i.e., T lymphocyte infiltration) and a milder course compared to the other patients Pediatric Immune Myelofibrosis is a novel and distinct pathological entity. We suggest to carefully consider Pediatric Immune Myelofibrosis in case of bone marrow biopsies showing myelofibrosis that do not fulfill WHO criteria.

Published
2022

8. Hemoglobin Monza: A New Variant of Unstable Hemoglobin

Author

Civettini, Ivan, Corti, Paola, Zappaterra, Arianna, Messina, Amedeo, Aroldi, Andrea, Biondi, Andrea, Cavalca, Fabrizio, Crosti, Francesca, Ferrari, Giulia Maria, Mologni, Luca, Piperno, Alberto, Ramazzotti, Daniele, Zambon, Alfonso, Rossi, Fabio, Scollo, Chiara, and Gambacorti-Passerini, Carlo

Published
2023
Full Text
View/download PDF

9. Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy

Author

Ferrari, A, Zecca, M, Rizzari, C, Porta, F, Provenzi, M, Marinoni, M, Schumacher, R, Luksch, R, Terenziani, M, Casanova, M, Spreafico, F, Chiaravalli, S, Compagno, F, Bruni, F, Piccolo, C, Bettini, L, D'Angiò, M, Ferrari, G, Biondi, A, Massimino, M, Balduzzi, A, Ferrari, Andrea, Zecca, Marco, Rizzari, Carmelo, Porta, Fulvio, Provenzi, Massimo, Marinoni, Maddalena, Schumacher, Richard Fabian, Luksch, Roberto, Terenziani, Monica, Casanova, Michela, Spreafico, Filippo, Chiaravalli, Stefano, Compagno, Francesca, Bruni, Federica, Piccolo, Chiara, Bettini, Laura, D'Angiò, Mariella, Ferrari, Giulia Maria, Biondi, Andrea, Massimino, Maura, Balduzzi, Adriana, Ferrari, A, Zecca, M, Rizzari, C, Porta, F, Provenzi, M, Marinoni, M, Schumacher, R, Luksch, R, Terenziani, M, Casanova, M, Spreafico, F, Chiaravalli, S, Compagno, F, Bruni, F, Piccolo, C, Bettini, L, D'Angiò, M, Ferrari, G, Biondi, A, Massimino, M, Balduzzi, A, Ferrari, Andrea, Zecca, Marco, Rizzari, Carmelo, Porta, Fulvio, Provenzi, Massimo, Marinoni, Maddalena, Schumacher, Richard Fabian, Luksch, Roberto, Terenziani, Monica, Casanova, Michela, Spreafico, Filippo, Chiaravalli, Stefano, Compagno, Francesca, Bruni, Federica, Piccolo, Chiara, Bettini, Laura, D'Angiò, Mariella, Ferrari, Giulia Maria, Biondi, Andrea, Massimino, Maura, and Balduzzi, Adriana

Published
2020

12. Legionellosi in Pediatria

Author

Impagnatiello, Luisa, primary, Bersanini, Chiara, additional, Spinelli, Marco, additional, Ferrari, Giulia Maria, additional, Biondi, Andrea, additional, and Rizzari, Carmelo, additional

Published
2020
Full Text
View/download PDF

13. Children with cancer in the time of COVID‐19: An 8‐week report from the six pediatric onco‐hematology centers in Lombardia, Italy

Author

Ferrari, Andrea, primary, Zecca, Marco, additional, Rizzari, Carmelo, additional, Porta, Fulvio, additional, Provenzi, Massimo, additional, Marinoni, Maddalena, additional, Schumacher, Richard Fabian, additional, Luksch, Roberto, additional, Terenziani, Monica, additional, Casanova, Michela, additional, Spreafico, Filippo, additional, Chiaravalli, Stefano, additional, Compagno, Francesca, additional, Bruni, Federica, additional, Piccolo, Chiara, additional, Bettini, Laura, additional, D'Angiò, Mariella, additional, Ferrari, Giulia Maria, additional, Biondi, Andrea, additional, Massimino, Maura, additional, and Balduzzi, Adriana, additional

Published
2020
Full Text
View/download PDF

14. Primary immunodeficiencies, autoimmune hyperthyroidism, coeliac disease and systemic lupus erythematosus in childhood immune thrombocytopenia.

Author

Saettini, Francesco, Cattoni, Alessandro, Redaelli, Martina, Silvestri, Daniela, Ferrari, Giulia Maria, Biondi, Andrea, Jankovic, Momcilo, and Spinelli, Marco

Subjects
SYSTEMIC lupus erythematosus, CELIAC disease, IDIOPATHIC thrombocytopenic purpura, HYPERTHYROIDISM, PEDIATRIC hematology
Abstract

Aim: To evaluate the cumulative prevalence of coeliac disease, systemic lupus erythematosus, autoimmune hyperthyroidism and primary immunodeficiencies in children with either newly diagnosed/persistent or chronic immune thrombocytopenia (ITP). Methods: Monocentric retrospective analysis of the clinical and biochemical features of 330 consecutive patients with ITP referred to our Pediatric Hematology Unit between January 2009 and December 2018. Results: The prevalence of systemic lupus erythematosus (0.3%), coeliac disease (0.3%) and autoimmune hyperthyroidism (0.6%) was not increased compared to general paediatric population. Of note, the prevalence of underlying primary immunodeficiencies was 2.4%, remarkably higher than the general paediatric population (P =.005). All the patients diagnosed with immunodeficiency developed either bi‐/trilinear cytopenia or splenomegaly. Conclusion: Whilst autoimmune and immunological screening is already recommended at the onset of immune thrombocytopenia, we recommend that primary immunodeficiencies be regularly screened during follow‐up, especially in case of additional cytopenia or lymphoproliferation. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

15. Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child

Author

Melzi, M, Ferrari, G, D' ADDA, A, Bovo, G, Foresti, S, Cavallero, A, Corso, R, Ciervo, A, Mancini, F, Biondi, A, MELZI, MARIA LUISA, FERRARI, GIULIA MARIA, D' ADDA, ANDREA, BIONDI, ANDREA, Melzi, M, Ferrari, G, D' ADDA, A, Bovo, G, Foresti, S, Cavallero, A, Corso, R, Ciervo, A, Mancini, F, Biondi, A, MELZI, MARIA LUISA, FERRARI, GIULIA MARIA, D' ADDA, ANDREA, and BIONDI, ANDREA

Published
2015

17. Rationale for a Pediatric-Inspired Approach in the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia, with a Focus on Asparaginase Treatment

Author

Rizzari, Carmelo, primary, Putti, Maria Caterina, additional, Colombini, Antonella, additional, Casagranda, Sara, additional, Ferrari, Giulia Maria, additional, Papayannidis, Cristina, additional, Iacobucci, Ilaria, additional, Abbenante, Maria Chiara, additional, Sartor, Chiara, additional, and Martinelli, Giovanni, additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results